Kyung Nam Pharm Co Ltd (053950) — Cash Flow Quality Index
Kyung Nam Pharm Co Ltd (053950) has a Cash Flow Quality Index of -0.53x as of March 2021. Operating cash flow of ₩-1.50 Billion is below net income of ₩2.85 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Kyung Nam Pharm Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kyung Nam Pharm Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Kyung Nam Pharm Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Kyung Nam Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Kyung Nam Pharm Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Kyung Nam Pharm Co Ltd. For live market cap and the full company financial profile, see Kyung Nam Pharm Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | ₩1.84 Billion | ₩10.08 Billion | ▲ +138.7% |
| 2018 | -0.47x | ₩-1.75 Billion | ₩3.72 Billion | ▼ -101.3% |
| 2016 | 37.66x | ₩4.89 Billion | ₩129.81 Million | — |